July 22, 2007

New Citations

1. Expanding the role of umbilical cord blood transplantation.
A detailed review of the state of the art and future directions with umbilical cord blood as a source of hematopoietic stem cells for transplantation in both children and adults. The article should be required reading for those interested in UCBT. See I. Recent Reviews, Citation 2

2. Umbilical cord blood transplantation for myeloid malignancies.
A detailed review of the available data on the outcomes of pediatric and adult patients with AML, MDS, and CML after UCBT. See I. Recent Reviews, Citation 3

3. Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplant outcomes in 110 adults with hematologic disease.
This report establishes the safety profile of a nonmyeloablative treatment regimen consisting of fludarabine, cyclophosphamide and single fraction TBI in recipients of UCB in 110 consecutive adults patients with hematological disease. Ninety-three of the 110 patients received a double cord transplant. See IV. Reduced Intensity and Non-Myeloablative Transplants, i. Cord Blood Transplants, Citation 3 (may also be found in III. Multi-Cord Transplants, Citation 1 and II. Transplantation of Adults, Citation 2)

4. Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukemia: a comparison study.
This study compared the leukemia-free survival after HSCT using allele-matched BMT and unrelated donor umbilical cord blood. The 5-year leukemia-free survival was similar. See VII. UCBT in Children, i. Malignant Disorders, Citation 1